HAE
What one share of Haemonetics holds
Surgical and Medical Instruments and Apparatus
Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components.
Haemonetics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-27; the balance sheet is as of 2026-06-27.
| Sales | $28.96 |
|---|---|
| Profit | $2.06 |
| Capex (buildings and equipment) | $0.79 |
| Free cash flow | $6.24 |
| Cash and investments | $4.91 |
| Debt | $25.82 |
| Book value | $18.41 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | $17.20 | −$0.51 | $1.48 | $1.62 | — | $14.15 |
| 2018 | $16.90 | $0.85 | $1.40 | $2.72 | — | $14.38 |
| 2019 | $18.28 | $1.04 | $2.25 | $0.76 | — | $13.09 |
| 2020 | $19.08 | $1.48 | $0.94 | $2.11 | — | $11.67 |
| 2021 | $16.97 | $1.55 | $0.72 | $1.40 | — | $14.38 |
| 2022 | $19.34 | $0.84 | $1.88 | $1.48 | — | $14.66 |
| 2023 | $22.73 | $2.24 | $3.72 | $1.59 | — | $16.21 |
| 2024 | $25.47 | $2.29 | $0.74 | $2.79 | — | $18.90 |
| 2025 | $26.82 | $3.31 | $0.77 | $2.81 | — | $17.02 |
| 2026 | $28.17 | $2.05 | $0.69 | $5.50 | — | $17.60 |